melphalan flufenamide , CAS No.380449-51-4

Item Number
M611785
Grouped product items
SKUSizeAvailabilityPrice Qty
M611785-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,300.90
M611785-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,000.90

Basic Description

SynonymsMelphalan flufenamide | Melflufen | Prodrug J-1 | Prodrug J 1 | J-1 (prodrug) | 380449-51-4 | J 1 (prodrug) | UNII-F70C5K4786 | F70C5K4786 | Melphalan flufenamide [USAN:INN] | WHO 9493 | 380449-51-4 (free base) | J-1 | L-Phenylalanine, 4-(bis(2-chloroethyl)amino)-l-phenylalanyl-4-
Specifications & PurityMoligand™
GradeMoligand™

Names and Identifiers

IUPAC Name ethyl (2S)-2-[[(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoyl]amino]-3-(4-fluorophenyl)propanoate
INCHI InChI=1S/C24H30Cl2FN3O3/c1-2-33-24(32)22(16-18-3-7-19(27)8-4-18)29-23(31)21(28)15-17-5-9-20(10-6-17)30(13-11-25)14-12-26/h3-10,21-22H,2,11-16,28H2,1H3,(H,29,31)/t21-,22-/m0/s1
InChi Key YQZNKYXGZSVEHI-VXKWHMMOSA-N
Canonical SMILES ClCCN(c1ccc(cc1)C[C@@H](C(=O)N[C@H](C(=O)OCC)Cc1ccc(cc1)F)N)CCCl
Isomeric SMILES CCOC(=O)[C@H](CC1=CC=C(C=C1)F)NC(=O)[C@H](CC2=CC=C(C=C2)N(CCCl)CCCl)N
PubChem CID 9935639

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Delforoush M, Strese S, Wickström M, Larsson R, Enblad G, Gullbo J.  (2016)  In vitro and in vivo activity of melflufen (J1)in lymphoma..  BMC Cancer,  16  (3): (263).  [PMID:27044263]
2. Oriol A, Larocca A, Leleu X, Hajek R, Hassoun H, Rodríguez-Otero P, Paner A, Schjesvold FH, Gullbo J, Richardson PG.  (2020)  Melflufen for relapsed and refractory multiple myeloma..  Expert Opin Investig Drugs,  29  (10): (1069-1078).  [PMID:32924646]
3. Richardson PG, Oriol A, Larocca A, Bladé J, Cavo M, Rodriguez-Otero P, Leleu X, Nadeem O, Hiemenz JW, Hassoun H et al..  (2021)  Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma..  J Clin Oncol,  39  (7): (757-767).  [PMID:33296242]
4. Dhillon S.  (2021)  Melphalan Flufenamide (Melflufen): First Approval..  Drugs,  81  (8): (963-969).  [PMID:33961277]
5. Byrgazov K, Besse A, Kraus M, Slipicevic A, Lehmann F, Driessen C, Besse L.  (2021)  Novel Peptide-drug Conjugate Melflufen Efficiently Eradicates Bortezomib-resistant Multiple Myeloma Cells Including Tumor-initiating Myeloma Progenitor Cells..  Hemasphere,  (7): (e602).  [PMID:34136753]

Solution Calculators